The Authors

David A. Sinclair, Ph.D.

David A. Sinclair, Ph.D. is a Professor in the Pathology Department at Harvard Medical School, Boston, and is Co-Director of the Glenn Laboratories for Aging Research. He is known for his research into genes and small molecules that control the body’s defenses against disease and aging. He has received numerous academic awards, has authored over 65 scientific publications, and was honored with being one of the “brightest minds under 45″ in 2006. In 2004 he co-founded Sirtris Pharmaceuticals to develop drugs to treat age-associated diseases, which was acquired by GlaxoSmithKline. In 2006, he co-founded Genocea Biosciences, a vaccine discovery company, to prevent diseases in developed and developing countries. Dr. Sinclair’s research has been featured in major print media and has appeared on Nightline, The Charlie Rose Show, 60 minutes, Barbara Walters Special, and Nova. He is currently a Senior Scholar of the Ellison Medical Foundation.

Mark S. Boguski, M.D., Ph.D.

Mark S. Boguski, M.D., Ph.D. is on the faculty of Harvard Medical School at the Francis Countway Library of Medicine and also in the Department of Pathology at Beth Israel Deaconess Medical CenterĀ  in Boston. He has previously held positions at the Johns Hopkins University School of Medicine, the U.S. National Institutes of Health, the U.S. National Library of Medicine and as an executive in the biotechnology and pharmaceutical industries. Dr. Boguski is a former vice president of Novartis and was honored as a Visionary and Influencer by the Personalized Medicine Coalition in 2006. He was elected to the Institute of Medicine of the U.S. National Academy of Sciences in 2001. Dr. Boguski is the Founder of Resounding Health Incorporated, a company dedicated to providing consumers with authoritative, reliable and timely online medical and health information.